The Asia-Pacific (APAC) region is poised to significantly drive the growth of the sleep apnea device market over the next five to ten years, according to a report by MarketsandMarkets. Key factors contributing to this growth include the expansion of leading industry players into emerging markets such as India, Australia, the UAE, and Saudi Arabia.
The report attributes the market’s growth to several factors, including an increase in comorbidities like diabetes and cardiovascular diseases, along with heightened awareness and diagnosis rates of sleep apnea.
Furthermore, the market’s expansion is supported by increased investments and funding, which are spurring innovations in Continuous Positive Airway Pressure (CPAP) devices and diagnostics. These advancements are improving patient compliance and accessibility to advanced solutions.
Globally, the sleep apnea device market is projected to reach $9.3 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.3%.